Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7733285

Concept 2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-09-30
Key financial data of group
Business results of group
Revenue
317,183,000,000 JPY
639,754,000,000 JPY
1,311,665,000,000 JPY
313,920,000,000 JPY
651,673,000,000 JPY
Profit (loss) before tax
101,224,000,000 JPY
281,769,000,000 JPY
157,772,000,000 JPY
Profit (loss), attributable to owners of parent
39,649,000,000 JPY
82,117,000,000 JPY
218,701,000,000 JPY
48,451,000,000 JPY
115,064,000,000 JPY
Comprehensive income, attributable to owners of parent
164,168,000,000 JPY
174,644,000,000 JPY
2,662,000,000 JPY
Equity attributable to owners of parent
1,350,907,000,000 JPY
1,271,810,000,000 JPY
1,227,253,000,000 JPY
Total assets
1,895,713,000,000 JPY
1,820,901,000,000 JPY
1,713,181,000,000 JPY
Basic earnings (loss) per share
19.39
39.97
103.69
22.80
54.16
Diluted earnings (loss) per share
39.92
103.55
54.08
Ratio of owners' equity to gross assets
0.713 xbrli:pure
0.698 xbrli:pure
0.716 xbrli:pure
Cash flows from (used in) operating activities
115,258,000,000 JPY
235,612,000,000 JPY
90,075,000,000 JPY
Cash flows from (used in) investing activities
-72,666,000,000 JPY
-73,383,000,000 JPY
-19,897,000,000 JPY
Cash flows from (used in) financing activities
-85,873,000,000 JPY
-166,153,000,000 JPY
-35,545,000,000 JPY
Cash and cash equivalents
307,923,000,000 JPY
340,923,000,000 JPY
366,325,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.